| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 01/10/2007 | EP1121114B1 Use of gaba analogs for the manufacture of a medicament for the treatment of mania and bipolar disorders |
| 01/10/2007 | EP1087946B1 Aryl alkanoylpyridazines |
| 01/10/2007 | EP1054672B1 Morphine sulphate microgranules, method for making same and pharmaceutical preparations |
| 01/10/2007 | EP1035856B1 Isolated dna encoding human h3 histamine receptor |
| 01/10/2007 | EP0821585B1 Use of alpha 1l-agonists in the treatment of urinary incontinence |
| 01/10/2007 | CN1894256A Method for preparing spironolactone compounds |
| 01/10/2007 | CN1894248A Synthesis of a polymorph of 4-amino-5-chlor0-2-methoxy-n-(1-azabicyclo[3.3.1]non-4-yl)benzamide hydrochloride hydrate |
| 01/10/2007 | CN1894244A Aryl ether substituted imidazoquinolines |
| 01/10/2007 | CN1894241A '1,2,4' oxadiazoles as modulators of metabotropic glutamate receptor-5 |
| 01/10/2007 | CN1894222A Condensed pyramidine compounds as inhibitors of voltage-gated ion channels |
| 01/10/2007 | CN1894217A Substituted dibenzo-azepine and benzo-diazepine derivatives useful as gamma-secretase inhibitors |
| 01/10/2007 | CN1894210A Prolinylarylacetamides |
| 01/10/2007 | CN1894195A Ether compounds and compositions for cholesterol management and related uses |
| 01/10/2007 | CN1893970A Beta-amyloid-analogue-cell epitop vaccine |
| 01/10/2007 | CN1893963A Production of hop extracts having oestrogenic and antiproliferative bioactivity |
| 01/10/2007 | CN1893961A Biologically active blood serum obtained by electroshock |
| 01/10/2007 | CN1893953A Tricyclic 1-((3-indol-3-yl)carbonyl)piperazine derivatives as cannabinoid cb1 receptor agonists |
| 01/10/2007 | CN1893942A Use of gaboxadol for treating insomnia |
| 01/10/2007 | CN1893935A The combination of a serotonin reuptake inhibitor and a histamine 3 receptor antagonist, inverse agonist or partial agonist |
| 01/10/2007 | CN1893934A Use of sphingosine-1-phosphate (s1p) receptor agonists for the treatment of brain degenerative diseases |
| 01/10/2007 | CN1893933A Materials and methods for improving alcohol metabolism and alleviating the effects of hangovers |
| 01/10/2007 | CN1893932A Microemulsion preconcentrate comprising a renin inhibitor |
| 01/10/2007 | CN1891300A Benzocaine film-formed gel composition and its use |
| 01/10/2007 | CN1891293A Chinese medicine for treating psychosis |
| 01/10/2007 | CN1891289A Chinese medicine for treating by-reaction disease caused by anti-psychosis medicine, and its preparing method |
| 01/10/2007 | CN1891287A Nano compound musk injection preparion, and its preparing method |
| 01/10/2007 | CN1891260A Corydalis decumbens extract, and its preparing method and use |
| 01/10/2007 | CN1891242A Production process for removing polycyclic aromatic hydrocarbons from ginkgo leaf extract |
| 01/10/2007 | CN1891228A Baicalin dropping pill and its preparing method |
| 01/10/2007 | CN1891220A 2-amino-3-(alkyl)-pyrimidone derivatives as gsk3.beta. inhibitors |
| 01/10/2007 | CN1891216A Use of catechin and its derivates for preparing medicine for preventing and treating neurodegenerative disease |
| 01/10/2007 | CN1891215A Compositions having an activity of ameliorating a reduced higher brain function resulting from organic brain lesions |
| 01/10/2007 | CN1891214A Compositions ameliorating a reduced diurnal activity and/or depressive symptoms |
| 01/10/2007 | CN1891213A Methods for preventing and treating peripheral neuropathy by administering desmethylselegiline delivery compositions |
| 01/10/2007 | CN1891209A Eplerenone crystalline form exhibiting enhanced dissolution rate |
| 01/10/2007 | CN1294136C Novel ligand for nicotinic acety/choline receptors useful in therapy |
| 01/10/2007 | CN1294133C Imidazo-pyrimidine derivatives as ligands for GABA receptors |
| 01/10/2007 | CN1294131C Pyrimidine compound |
| 01/10/2007 | CN1294117C Amidino compound and salts thereof useful as nitric oxide synahase inhibitors |
| 01/10/2007 | CN1293914C Process for preparing pharmaceutical composition for improving sleep and health |
| 01/10/2007 | CN1293911C Process for preparing medicine for treating headache |
| 01/10/2007 | CN1293910C Compound gastrodin injection and its preparation and use |
| 01/10/2007 | CN1293904C Tea capable of sobering up, nourishing stomach and protecting liver |
| 01/10/2007 | CN1293894C Medicine for stopping drug addition and its preparation process |
| 01/10/2007 | CN1293877C Neurotrophic tacrolimus analogs |
| 01/10/2007 | CN1293865C Cell growth regulating factor R and its preparation process |
| 01/10/2007 | CN1293825C Application of dihydromyricetin in preparation of food, cosmetics or medicine |
| 01/09/2007 | US7161035 Substituted biphenyl derivatives, method for preparing same and pharmaceutical compositions containing same |
| 01/09/2007 | US7161006 Enzyme inhibitors for treatment of Alzhemer's Disease |
| 01/09/2007 | US7160922 Biphenyl-4-carboxylic acid-(6-(1-((4-fluorobenzyl)methylamino)ethylideneamino)-2-hydroxyindan-1-yl)amide; cognitive activators, attention deficit/hyperactivity disorder, obesity, Alzheimer's disease, psychoses, schizophrenia; hypotensive agents for glaucoma |
| 01/09/2007 | US7160905 Hydroxyethylene compounds with Asp2 inhibitory activity |
| 01/09/2007 | US7160900 Tetrahydropyridino or piperidino heterocyclic derivatives |
| 01/09/2007 | US7160899 Use of at least one compound with neurotrophic activity and at least one adenosine A2A receptor antagonist for the manufacture of a medicament for the treatment, prevention or alleviation of Parkinson's disease in a subject |
| 01/09/2007 | US7160894 Antagonist of phosphorylation of myosin regulatory light chain, enzyme inhibitors; therapeutic treatment of glaucoma, bronchial asthma, chronic obstructive pulmonary disease, nervous system disorders; 4-(2,3-dihydro-1,5-diazaphenalen-1-yl)cyclohexylamine |
| 01/09/2007 | US7160892 Pyrimidone compounds and pharmaceutical compositions containing the same |
| 01/09/2007 | US7160888 7-[4-(4-naphthalen-1-yl-piperazin-1-yl)-butoxy]-3,4-dihydro-1H-[1,8]naphthyridin-2-one; use in the treatment of central nervous system disorders, bipolar disorder in a human |
| 01/09/2007 | US7160881 Crystalline modifications of 2-(3,5-bis-trifluoromethyl-phenyl)-N-[6-(1,1-dioxo-1 λ6-thiomorpholin-4-yl)-4-(4-fluoro-2-methyl-phenyl)-pyridin-3-yl]-N-methyl-isobutyramide |
| 01/09/2007 | US7160880 Producing sedation, hypnosis, inducing anxiolysis, muscle relaxation; treating convulsions; CNS depressants; pharmacodynamic |
| 01/09/2007 | US7160879 Melanin concentrating hormone receptor ligands: substituted 2-(4-benzyl-piperazin-1-ylmethyl)- and 2-(4-benzyl-diazepan-1-ylmethyl)-1H-benzoimidazole analogues |
| 01/09/2007 | US7160875 Malonamide derivatives |
| 01/09/2007 | US7160872 Methods to treat conditions mediated by chemokine receptors |
| 01/09/2007 | US7160724 Cells for use in the treatment of nervous system disorders |
| 01/09/2007 | US7160559 Galantamine hydrobromide particles and a water soluble film forming polymer are layered or coated on inert spheres, covered by a release rate controlling membrane made of a water insoluble polymer and optionally a plasticizer; galantamine and water-soluble polymer topcoat |
| 01/09/2007 | US7160558 Coating and binding agent for pharmaceutical formulations with improved storage stability |
| 01/09/2007 | US7160541 Modified polypeptides stabilized in a desired conformation and methods for producing same |
| 01/09/2007 | CA2467490C Pharmaceutical compositions of 5,8,14-triazatetracyclo[10.3.1.0(2,11).0(4,9)]-hexadeca-2(11)3,5,7,9-pentaene |
| 01/09/2007 | CA2407538C Novel bicyclic compounds |
| 01/09/2007 | CA2389325C 1-amino-alkylcyclohexane nmda receptor antagonists |
| 01/09/2007 | CA2344407C Method for the treatment of mania and bipolar disorder |
| 01/09/2007 | CA2338276C Fkbp inhibitors |
| 01/09/2007 | CA2295177C Drug targeting system, method of its preparation and its use |
| 01/09/2007 | CA2266444C Olanzapine dihydrate d |
| 01/09/2007 | CA2260145C Use of l-acetylcarnitine, l-isovalerylcarnitine, l-propionylcarnitine for increasing the levels of igf-1 |
| 01/09/2007 | CA2223011C Oxazolidinone derivatives, their preparation and therapeutical use |
| 01/09/2007 | CA2186844C Use of serotonin antagonists (5ht3) for treating fibromyalgia |
| 01/09/2007 | CA2176511C Biologically active silicon compounds and their therapeutic and cosmetic applications |
| 01/09/2007 | CA2142700C 3-oxo-pyrido(1,2-a)benzimidazole-4-carboxyl and 4-oxo-azepino(1,2-a)benzimidazole-5-carboxyl derivatives useful in treating central nervous system disorders |
| 01/09/2007 | CA2077637C Compositions comprising a tramadol material and any of codeine, oxycodone or hydrocodone and their use |
| 01/04/2007 | WO2007002528A1 Anti-aging micrornas |
| 01/04/2007 | WO2007002114A1 1,2-dihydro-spiro(3h-indole-3-4’-piperidine) compounds as modulators of the mas receptor novel |
| 01/04/2007 | WO2007001939A1 Tetrahydro-pyranopyrazole compounds displaying cannabinoid modulating activities |
| 01/04/2007 | WO2007001225A1 Thiophene-2-carboxamide derivatives as alpha 7 nicotinic receptor modulators. |
| 01/04/2007 | WO2007001058A1 Herpesvirus-derived therapeutic agent for pain |
| 01/04/2007 | WO2007001010A1 Pharmaceutical for treatment of parkinson’s disease |
| 01/04/2007 | WO2007000970A1 Therapeutic agent for pain |
| 01/04/2007 | WO2007000967A1 Remedy for cerebral infarction |
| 01/04/2007 | WO2007000465A1 Novel 3-aza-spiro[5.5]undecane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 01/04/2007 | WO2007000464A1 Novel 3-aza-spiro[5.5]undec-8-ene derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 01/04/2007 | WO2007000463A1 Novel 3,9-diaza-spiro[5.5]undecane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 01/04/2007 | WO2007000241A1 Pyrazolopyridine derivatives as inhibitors of beta-adrenergic receptor kinase 1 |
| 01/04/2007 | WO2005097138A3 Combinations comprising oxcarbazepine to treat affective disorders |
| 01/04/2007 | US20070004807 Methods using phenethanolamine derivatives for treatment of respiratory diseases |
| 01/04/2007 | US20070004721 Pteridine derivatives for the treatment of septic shock and tnf-a-related diseases |
| 01/04/2007 | US20070004718 Ion channel modulating compounds and uses thereof |
| 01/04/2007 | US20070004716 Carboxylic acid compounds and medicinal compositions containing the same as the active ingredient |
| 01/04/2007 | US20070004713 Therapeutic benimidazole compounds |
| 01/04/2007 | US20070004709 excitatory amino acid receptors modulators; for the treatment or prevention of disorders of memory and cognition; 6-chloro-4-ethyl-3,4-dihydro-2H-thieno[3,2-e][1,2,4]thiadiazine 1,1-dioxide; anxiety; depression; progressive neurodegenerative diseases |
| 01/04/2007 | US20070004707 5HT2c agonists or partial agonists; e.g., 4,5,6,7,9a,10,11,12,13,13a-decahydro-9H-(1,4)diazepino-(6,7,1 -de)phenanthridine hydrochloride; schizophrenia, Parkinson's disease, psychosis associated with Lewy body disease, dementia, memory deficit; psychosis |
| 01/04/2007 | US20070004706 New polymorphs of olanzapine hydrochloride |
| 01/04/2007 | US20070004705 Substituted pyrrolo-pyrazole derivatives as kinase inhibitors |